Geron Corporation, based in Parsippany, is a clinical stage biopharmaceutical company specializing in the development of imetelstat, a telomerase inhibitor.
The company's primary focus is on advancing imetelstat for the treatment of hematologic myeloid malignancies, demonstrating its commitment to addressing critical medical needs in this area.
Generated from their website's infomation